Catherine Anastasopoulou, MD, PhD

Albert Einstein Healthcare Network · Einstein Medical Center Philadelphia.

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

1 more share only the name and are not shown

Trial papers

PubMed author-name match

Trials

Studies that name Catherine Anastasopoulou, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:14 UTC. Open this list on ClinicalTrials.gov

N/A
NCT04277780 · Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge
Albert Einstein Healthcare Network · terminated · Type 2 Diabetes Mellitus · principal investigator
Ph2
NCT04231682 · A Study to Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.
Albert Einstein Healthcare Network · withdrawn · Osteoporosis · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.